Hip arthritis is a form of degenerative joint disease that affects millions of Americans. Patients try to delay hip replacement surgery for as long as possible and often seek hip injections with steroids. Steroid injection is not favored as a viable long term treatment since the steroids actually damage local tissues over time. Certain types of hip problems including certain fractures and injuries may not be amenable to cell therapy. It is important to evaluate each individual case to assess likelihood of success with attempting regenerative therapy. has developed a degenerative hip disease SVF deployment protocol that attempts to exploit the anti-inflammatory and healing effects of SVF (rich in mesenchymal stem cells and growth factors). SVF is injected using local anesthesia under radiographic guidance using CAT scanning to ensure that the injection is accurate. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.
